1998
DOI: 10.1097/00008571-199806000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Genetic analysis of the cytochrome P450 CYP2D6 polymorphism in patients with systemic lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…The inactive CYP2D6*4A allele may be a contributory factor for SLE [33]. After genotyping 90 SLE patients and 94 healthy controls, Yen et al [34] concluded that CYP1A1 4887A may be a precipitating factor for SLE, and they detected a synergistic effect for SLE susceptibility between CYP1A1 4887C/A and Mn SOD 1183T/T.…”
Section: Discussionmentioning
confidence: 99%
“…The inactive CYP2D6*4A allele may be a contributory factor for SLE [33]. After genotyping 90 SLE patients and 94 healthy controls, Yen et al [34] concluded that CYP1A1 4887A may be a precipitating factor for SLE, and they detected a synergistic effect for SLE susceptibility between CYP1A1 4887C/A and Mn SOD 1183T/T.…”
Section: Discussionmentioning
confidence: 99%
“…May et al evaluated that the relative risk of SSc development was 10-fold higher (P=0.008) in patients with poor metabolism of mephenitoin and dapsone. This complex metabolic impairment may contribute to SSc development, or, on the other hand, the pathological process could be solely responsible for inhibition of selected enzymes metabolizing xenobiotics in some groups of patients [1]. Investigating the distribution of CYP1A1 polymorphisms, von Schmiedeberg et al did not observe significant differences among SSc patients in comparison to a healthy population [2].…”
Section: Discussionmentioning
confidence: 98%
“…First investigations on the association between the oxidative genotype and autoimmune diseases were conducted in the 1990s. Studies have demonstrated that oxidative polymorphism is not associated with the risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) development [1,2,8].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the difference was not statistically significant. The CYP2D6*4 allele was observed to occur more often in SLE patients in whom renal or hematological lesions had been observed [ 35 ].…”
Section: Discussionmentioning
confidence: 99%